Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

JAYPIRCA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/JAYPIRCA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

JAYPIRCA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Eli Lilly Nederland B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 27, 2023
Approval ID: ed813e3fab146e1c
Company: Eli Lilly Nederland B.V.
Type: Standard

Approval Details

Approval Id: ed813e3fab146e1c
Drug Cima Aemps Name: JAYPIRCA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 1231738007
Holder Company Name: Eli Lilly Nederland B.V.
Marketing Company Name: Lilly S.A.
Holder Company Detail Path: /organization/eli-lilly-nederland-bv
Marketing Company Detail Path: /organization/lilly-sa
Authorization Date: 2023-11-27
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 100 MG
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Eli Lilly Nederland B.V.
Company Detail Path: /organization/eli-lilly-nederland-bv

Company Information

Pharmaceutical Company Name: Eli Lilly Nederland BV
Country Name: Netherlands
Website: http://www.lilly.com/nl

Active Ingredients

PIRTOBRUTINIB

100 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 27, 2023

Approval ID

ed813e3fab146e1c

Type

Standard

Back to CIMA-AEMPS Approvals